COLUMN GROUP II, LP

Profile

Company Names

COLUMN GROUP II, LP

Addresses

1700 OWENS STREET, SUITE 500, SAN FRANCISCO, CA 94158

Phone Numbers

4158652050

 

Entity Type:

LIMITED PARTNERSHIP

Industry:

VENTURE CAPITAL FUND

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$306,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2014-04-04 
$306,000,000.00 
$306,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
V. 
GOEDDEL, PH.D. 
EXECUTIVE OFFICER
COLUMN GROUP II, LP
TIM 
 
KUTZKEY, PH.D. 
EXECUTIVE OFFICER
COLUMN GROUP II, LP   |  SURROZEN, INC./DE
LAURENCE 
 
LASKY, PH.D. 
EXECUTIVE OFFICER
COLUMN GROUP II, LP   |  EFFECTOR THERAPEUTICS, INC.
PETER 
 
SVENNILSON 
EXECUTIVE OFFICER
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-09-16
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-04 
2014-04-11
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#